Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 28,675.0 | 24,486.0 | 23,253.0 | 24,348.0 | 23,757.0 | 23,565.0 | 22,743.0 | 22,371.0 |
Revenue growth | 17.1% | 5.3% | -4.5% | 2.5% | 0.8% | 3.6% | 1.7% | -0.6% |
Cost of goods sold | 20,856.0 | 17,413.0 | 16,506.0 | 18,071.0 | 18,154.0 | 6,350.0 | 6,890.0 | 3,194.0 |
Gross profit | 7,819.0 | 7,073.0 | 6,747.0 | 6,277.0 | 5,603.0 | 17,215.0 | 15,853.0 | 19,177.0 |
Gross margin | 27.3% | 28.9% | 29.0% | 25.8% | 23.6% | 73.1% | 69.7% | 85.7% |
Selling, general and administrative | | | | | | | | |
General and administrative | 1,466.0 | 1,355.0 | 1,311.0 | 1,307.0 | 1,280.0 | 1,233.0 | 1,142.0 | 1,129.0 |
EBITA | 6,581.0 | 5,927.0 | 3,555.0 | 5,859.0 | 5,081.0 | 6,054.0 | 5,232.0 | 5,288.0 |
EBITA margin | 23.0% | 24.2% | 15.3% | 24.1% | 21.4% | 25.7% | 23.0% | 23.6% |
Amortization of intangibles | | | | | | | | 5.0 |
EBIT | 6,581.0 | 5,927.0 | 3,555.0 | 5,859.0 | 5,081.0 | 6,054.0 | 5,232.0 | 5,283.0 |
EBIT margin | 23.0% | 24.2% | 15.3% | 24.1% | 21.4% | 25.7% | 23.0% | 23.6% |
Pre-tax income | 4,078.0 | 3,991.0 | 920.0 | 4,097.0 | 3,073.0 | 4,266.0 | 3,734.0 | 3,910.0 |
Income taxes | 300.0 | 268.0 | -169.0 | 519.0 | 448.0 | 1,196.0 | 2,282.0 | 1,345.0 |
Tax rate | 7.4% | 6.7% | | 12.7% | 14.6% | 28.0% | 61.1% | 34.4% |
Earnings from continuing ops | 3,767.0 | 3,946.0 | 1,277.0 | 3,714.0 | 2,647.0 | 3,065.0 | 5,138.0 | 2,639.0 |
Earnings from discontinued ops | -1,323.0 | -144.0 | -7.0 | -7.0 | 19.0 | -6.0 | -408.0 | 177.0 |
Net income | 2,444.0 | 3,802.0 | 1,270.0 | 3,707.0 | 2,666.0 | 3,059.0 | 4,730.0 | 2,816.0 |
Net margin | 8.5% | 15.5% | 5.5% | 15.2% | 11.2% | 13.0% | 20.8% | 12.6% |
|
Diluted EPS | $4.89 | $5.13 | $1.73 | $5.09 | $3.74 | $4.38 | $7.44 | $3.80 |
Shares outstanding (diluted) | 770.0 | 769.0 | 738.0 | 729.0 | 708.0 | 700.0 | 691.0 | 694.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|